Abstract
There are several major biomedical applications where the transplantation of immobilized cells is being employed to restore, maintain or improve tissue function. These strategies can be split into two main categories: the replacement of biochemical function only or the replacement of structurally functional tissue. As only chemical communication (e.g., diffusion of molecules) is required in the former, it is possible to deliver cells encapsulated in a nanoporous, immunoisolatory polymer membrane. The membranes is constructed such that there are pores large enough to allow for nutrients, waste and the bioactive factor to diffuse but not large enough as to allow immune cells to attack the cells within [1]. This strategy has mainly been employed to temporarily or permanently replace biochemical functions of the liver [2,3], pancreas [4,5], and provide local protein delivery in neurological disorders [6]. The second major strategy involves entrapping cells on a micro or macroporous polymer scaffold and promoting the formation of a new tissue that is structurally and functionally integrated with the surrounding tissue. The scaffold is constructed with a biocompatible material that degrades over time to leave only the integrated tissue in its place. Researchers have attempted to use this strategy with a variety of tissues, including skin [7,8,9], liver [10,11,12], pancreas [13], cornea [14], blood vessels [15,16], cartilage [17,18], heart [19], and bone [20,21].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Langer, R. (2000) Tissue Engineering: Status and Challenges. E-biomed. 1: 5–6.
Elcin, Y.M.; Dixit, V.; Lwein, K. and Gitnick, G. (1999) Xenotransplantation of fetal porcine hepatocytes in rats using a tissue engineering approach. Artif. Organs 23 (2): 146–152.
Dixit, V. (1995) Transplantation of isolated hepatocytes and their role in extrahepatic life support systems. Scand. J. Gastroenterol. Suppl. 208: 101–110.
Lanza, R.P.; Sullivan, S.J. and Chick, W.L. (1992) Islet transplantation with immunoisolation. Diabetes. 41: 1503–1510.
O’Shea, G.M.; Goosen, M.F. and Sun, A.M. (1984) Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim. Biophys. Acta 804 (1): 133–136.
Sagen, J.; Bruhn, S.L.; Rein, D.H.; Li, R.H. and Carpenter, M.K. (1999) Transplantation of encapsulated cells into the central nervous system. In: Kuhtreiber, W.M.; Lanza, R.P. and Chick, W.L. (Eds.) Cell Encapsulation Technology and Therapeutics. Birkhauser, Boston; pp. 351–378.
Hansbrough, J.F.; Cooper, M.L.; Cohen, R.; Spielvogel, R.; Greenleaf, G.; Bartel, R.L. and Naughton, G. (1992) Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery. 111 (4): 438–446.
Ma, J.; Wang, H.; He, B. and Chen, J. (2001) A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts. Biomaterials 22 (4): 331–336.
Galassi, G.; Brun, P.; Radice, M.; Cortivo, R.; Zanon, G.F.; Genovese, P. and Abatangelo, G. (2000) In vitro reconstructed dermis implanted in human wounds: degradation studies of the HA-based supporting scaffold. Biomaterials 21(21) 2183–2191.
Watanabe, F.D.; Mullon, C.J.; Hewitt, W.R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaout, W.; Shackleton, C.R.; Rozga, J.; Solomon, B. and Demetriou, AA. (1997) Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase 1 clinical trial. Ann Surg 225 (5): 484–494.
Cima, L.G.; Vacanti, J.P.; Vacanti, C.; Ingber, D.; Mooney, D. and Langer, R. (1991) Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng. 113 (2): 143–151.
Kim, S.S.; Utsunomiya, H.; Koski, J.A.; Wu, B.M.; Cima, M.J.; Sohn, J.; Mukai, K.; Griffith, L.G. and Vacanti, J.P. (1998) Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels Ann. Surg. 228 (1): 8–13.
Sullivan, S.J.; Maki, T.; Borland, K.M.; Mahoney, M.D.; Solomon, B.A.; Muller, T.E.; Monaco, A.P. and Chick, W.L. (1991) Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 252 (5006): 718–721.
Kobayashi, H.; Ikada, Y.; Moritera, T.; Ogura, Y. and Honda, Y. (1991) Collagen-immobilized hydrogel as a material for lamellar keratoplasty. J. Appl. Biomater. 2 (4): 261–267.
Niklason, L.E.; Gao, J.; Abbott, W.M.; Hirschi, K.K.; Houser, S.; Marini, R.; Langer, R. (1999) Functional arteries grown in vitro. Science 284 (5413): 489–493.
Miwa, H.; Matsuda, T. and Iida, F. (1993) Development of a hierarchically structured hybrid vascular graft biomimicking natural arteries. ASAIO J. 39 (3): M273–277.
Metters, A.T.; Anseth, K.S. and Bowman, C.N. (1999) Fundamental studies of biodegradable hydrogels as cartilage replacement materials. Biomed. Sci. Instrum 35 . 33–38.
Vacanti, C.A.; Langer, R.; Schloo, B. and Vacanti, J.P. (1991) Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast. Reconstru. Surg. 88 (5): 753–759.
Sodian, R.; Sperling, J.S.; Martin, D.P.; Stock, U.; Mayer, J.E., Jr. and Vacanti, J.P. (1999) Tissue engineering of a trileaflet heart valve-early in vitro experiences with a combined polymer. Tissue Eng. 5 (5): 489–494.
Crane, G.M.; Ishaug, S.L.; Mikos, A.G. (1995) Bone tissue engineering. Nat. Med. 1 (12): 1322–1324.
Solchaga, L.A.; Dennis, J.E.; Goldberg, V.M. and Caplan, A.I. (1999) Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J. Orthop. Res. 17 (2): 205–213.
Brittberg, M.; Lindahl, A.; Nilsson, A.; Ohlsson, C.; Isaksson, O. and Peterson, L. (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331 (14): 889–895.
Auger, F.A.; Pouliot, R.; Tremblay, N.; Guignard, R.; Noel, P.; Juhasz, J.; Germain, L. and Goulet, F. (2000) Multistep production of bioengineered skin substitutes: sequential modulation of culture conditions. In Vitro Cell Dev. Biol. Anim. 36 (2): 96–103.
Hardin-Young, J.; Teumer, J.; Ross, R.N. and Parenteau, N.L. (2000) Approaches to transplanting engineered cells and tissues. In: Lanza, R.P.; Langer, R. and Vacanti, J. (Eds.) Principles of Tissue Engineering. Academic Press, San Diego; pp. 281–292.
MacKay, S.M.; Funke, A.J.; Buffington, D.A. and Humes, H.D. (1998) Tissue engineering of a bioartificial renal tubule. ASAIO J. 44 (3): 179–183.
Wandrey, C. and Vidal, D.S. (2001) Purificaiton of polymeric biomaterials. Ann. N.Y. Acad. Sci. 944: 187–198.
Rozga, J. and Demetriou, A.A. (1995) Artificial liver. Evolution and future perspectives. ASAIO J. 41 (4): 831–837.
Khalil, M.; Shariat-Panahi, A.; Tootle, R.; Ryder, T.; McCloskey, P.; Roberts, E.; Hodgson, H. and Selden, C. (2001) Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J. Hepatol. 34 (1): 68–77.
Rihova, B. (2000) Immunocompatibility and biocompatibility of cell delivery systems. Adv. Drug Deliv. Rev. 42 (1–2) 65–80.
Hui, T.; Rozga, J. and Demetriou, A.A. (2001) Bioartificial liver support. J. Hepatobiliary Pancreat. Surg. 8 (1): 1–15.
Zielinski, B.A. and Lysaght, M.J. (2000) Immunoisolation. In: Lanza, R.P.; Langer, R. and Vacanti, J. (Eds.) Principles of Tissue Engineering. Academic Press, San Diego; pp. 321–330.
Langer, R. (2000) Tissue Engineering. Mol. Ther. 1 (1): 12–15.
Sagen, J.; Hama, A.T.; Winn, S.R. et al.,(1993) Pain reduction by spinal implantation of xenogeneic chromaffin cells immunologically-isolated in polymer capsules. Neurosci. Abstracts. 19: 234.
Joseph, J.M.; Goddard, M.B.; Mills, J.; Padrun, V.; Zum, A.; Zielinski, B.; Favre, J.; Gardaz, J.P.; Mosimann, F.; Sagen, J.; Christenson, L. and Aebischer, P. (1994) Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Cell Transplant. 3 (5): 355–364.
Aebischer, P.; Russell, P.C.; Christenson, L.; Panol, G.; Monchik, J.M. and Galletti, P.M. (1986) A bioartificial parathyroid. ASAIO Trans. 32 (1): 134–137.
Chang, P.L.; Shen, N. and Westcott, A.J. (1993) Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4 (4): 433–440.
Koo, J. and Chang, T.M. (1993) Secretion of erythropoietin from microencapsulated rat kidney cells: preliminary results. Int. J. Artif. Organs 16 (7): 557–560.
Rinsch, C.; Regulier, E.; Deglon, N.; Dalle, B.; Beuzard, Y. and Aebischer, P. (1997) A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum. Gene Ther. 8 (16): 1881–1889.
Colton, C.K. (1995) Implantable biohybrid artificial organs. Cell Transplant. 4 (4): 415–436.
Brauker, J.; Frost, G.H.; Dwarki, V.; Nijjar, T.; Chin, R.; Carr-Brendel, V.; Jasunas, C.; Hodgett, D.; Stone, W.; Cohen, L.K. and Johnson, R.C. (1998) Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents. Hum. Gene Ther. 9 (6): 879–888.
Mullon, C. and Solomon, B.A. (2000) HepatAssist liver support system. In: Lanza, R.P., Langer, R. and Vacanti, J. Principles of Tissue Engineering, Academic Press, San Deigo; pp 553–558.
Alberts, B.; Bray, D.; Lewis, J.; Raff, M.; Roberts, K. and Watson, J.D. (1989) Molecular Biology of the Cell. Garland Publishing Inc., New York, New York.
Lee, M.K. and Bae, Y.H. (2000) Cell transplantation for endocrine disorders. Adv. Drug Deliv. Rev. 42 (1–2): 103–120.
Wang, T.G. (1999) Polymer membranes for cell encapsulation. In: Kuhtreiber, W.M.; Lanza, R.P. and Chick, W.L. (Eds.) Cell Encapsulation Technology and Therapeutics. Birkhauser, Boston; pp. 29–39.
Iwata, H.; Park, G. and Ikada, Y. (1998) A model for oxygen transport in microencapsulated islets. In Thomson, R.C.; Mooney, D.J.; Healy, K.E.; Ikada, Y. and Mikos, A.G. (Eds.) Biomaterials Regulating Cell Function and Tissue Development. ( 530 ) MRS Symposium Preceedings, MRS, Warrendale; pp. 19–24.
Uludag, H.; De Vos, P. and Tresco, P.A. (2000) Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 42 (1–2) 29–64.
Geller, R.L.; Loudovaris, T.; Neuenfeldt, S.; Johnson, R.C. and Brauker, J.H. (1997) Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Ann. N.Y. Acad. Science 831: 438–451.
Ezzell, C. (1995) Tissue Engineering and the Human Body Shop: Encapsulated-Cell Transplants Enter the Clinic. J. NIH Res. 7: 47–51.
Lanza, R.P.; Jackson, R.; Sullivan, A.; Ringeling, J.; McGrath, C.; Kuhtreiber, W. and Chick, W.L. (1999) Xenotransplantation of cells using biodegradable microcapsules. Transplantation 67 (8) 1105–1111.
Aebischer, P.; Buchser, E.; Joseph, J.M.; Favre, J.; de Tribolet, N.; Lysaght, M.; Rudnick, S. and Goddard, M. (1994) Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary report. Transplantation 58 (11): 1275–1277.
Zielinski, B.A. and Aebischer, P. (1994) Chtiosan as a matrix for mammalian cell encapsulation. Biomaterials 15 (13): 1049–1056.
Suh, J.K. and Matthew, H.W. (2000) Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 21 (24): 2589–2598.
Shea, L.D.; Wang, D.; Franceschi, R.T. and Mooney, D.J. (2000) Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng. 6 (6): 605–617.
Mann, B.K. and West J.L. (2001) Tissue engineering in the cardiovascular system: progress toward a tissue engineered heart. Anat Rec. 263 (4): 367–371.
Wildevuur, C.R.; van der Lei, B. and Schakenraad, J.M. (1987) Basic aspects of the regeneration of small-calibre neoarteries in biodegradable vascular grafts in rats. Biomaterials 8 (6): 418–422.
Mooney, D.J. and Langer, R.S. (2000) Engineering Biomaterials for Tissue Engineering: The 10–100 micron size scale. In: Bronzino, J.D. (Ed.) The Biomedical Engineeing Handbook. CRC Press LLC; p. 112.
Agrawal, C.M. and Ray, R. B. (2001) Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J. Biomed. Mater. Res. 55 (2): 141–150.
Kim, B.S.; Nikolovski, J.; Bonadio, J. and Mooney, D.J. (1999) Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat. Biotechnol. 17 (10): 979–983.
Ziegler, T.; Alexander, R.W. and Nerem, R.M. (1995) An endothelial cell-smooth muscle cell co-culture model for use in the investigation of flow effects on vascular biology. Ann. Biomed. Eng. 23 (3): 216–225.
Hunter, C.J.; Imler, S.M.; Malaviya, P.; Nerem, R.M. and Levenston, M.E. (2000) Mechanical compression alters gene expression and extracellular matrix synthesis by chondrocytes cultured in collagen I gels. Biomaterials 23 (4): 1249–1259.
Niklason, L.E. and Langer, R. S. (1997) Advances in tissue engineering of blood vessels and other tissues. Transpl. Immunol. 5 (4): 303–306.
Carver, S.E. and Heath, C.A. (1999) Influence of intermittent pressure, fluid flow, and mixing on the regenerative properties of articular chondrocytes. Biotechnol. Bioeng. 65 (3): 274–281.
Andriano, K.P.; Tabata, Y.; Ikada, Y. and Heller, J. (1999) In vitro and in vivo comparison of bulk and surface hydrolysis in absorbable polymer scaffolds for tissue engineering. J. Biomed. Mater. Res. 48(5): 602–612.
lordanskii, A.L.; Rudakova, T.E. and Zaikov, G.E. (1994) Interaction of Polymers with Bioactive and Corrosive Media. In series: New Concepts in Polymer Science, VSP, Utrecht.
Hubbell, J.A. (1999) Bioactive Biomaterials. Cuir. Opin. Biotechnol. 10 (2): 123–129.
Hem, D.L. and Hubbell, J.A. (1998) Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. 39 (2): 266–276.
Alsberg, E.; Anderson, K.W.; Albeiruti, A.; Franceschi, R.T. and Mooney, D.J. (2000) Cell-interactive alginate hydrogels for bone tissue engineering. J. Dent. Res. 80 (11): 2025–2029.
Cook, A.D.; Hrkach, J.S.; Gao, N.N.; Johnson, I.M.; Pajvani, U.B.; Cannizzaro, S.M. and Langer, R. (1997) Characterization and development of ROD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J. Biomed. Mater. Res. 35 (4): 513–523.
Yu, X.; Dillon, G.P. and Bellamkonda, R.B. (1999) A laminin and nerve growth factor-laden three-dimensional scaffold for enhanced neurite extension. Tissue Eng. 5 (4): 291–304.
Ito, Y.; Chen, G. and Imanishi, Y. (1998) Artificial juxtacrine stimulation for tissue engineering. J. Biomater. Sci. Polym. Ed. 9(8): 879–890.
Han, S.; Mahato, R.I.; Sung, Y.K. and Kim, S.W. (2000) Development of biomaterials for gene thereapy. Mol. Ther. 2 (4): 302–317.
Rosenblatt, J.; Devereux, B. and Wallace, D.G. (1994) Injectable collagen as a pH-sensitive hydrogel. Biomaterials 15 (12): 985–995.
Senuma, Y.; Franceschin, S.; Hilborn, J.G.; Tissieres, P.; Bisson, I. and Frey, P. (2000) Bioresorbable microspheres by spinning disk atomization as injectable cell carrier: from preparation to in vitro evaluation. Biomaterials 21 (11): 1135–1144.
Chevallay, B. and Herbage, D. (2000) Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med. Biol. Eng. Comput. 38 (2): 211–218.
Roche, S.; Ronziere, M.C.; Herbage, D. and Freyria, A.M. (2001) Native and DPPA cross-linked collagen sponges seeded with fetal bovine epiphyseal chondrocytes used for cartilage tissue engineering. Biomaterials 22 (1): 9–18.
Lee, C.H.; Singla, A. and Lee, Y. (2001) Biomedical applications of collagen. Int. J. Pharm. 221 (1–2): 122.
Yannas, I.V.; Lee, E.; Orgill, D.P.; Skrabut, E.M. and Murphy, G.F. (1989) Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc. Natl. Acad. Sci. USA 86 (3): 933–937.
Yamada, N.; Uchinuma, E. and Kuroyanagi, Y. (1999) Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scand. J. Plast. Reconstr. Surg. Han. Surg. 33 (2): 147–154.
Nimni, M.E.; Bernick, S.; Cheung, D.T.; Ertl, D.C.; Nishimoto, S.K.; Paule, W.J.; Salka, C. and Strates, B.S. (1988) Biochemical differences between dystrophic calcification of cross-linked collagen implants and mineralization during bone induction. Calcif. Tiddue Int. 42 (5): 313–320.
Murata, M.; Huang, B. Z.; Shibata, T.; Imai, S.; Nagai, N. and Arisue, M. (1999) Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone. Int. J. Oral Maxillofac. Surg. 28 (3): 232–237.
Ratcliffe, A. (2000) Tissue engineering of vascular grafts. Matrix Biol. 19 (4): 353–357.
Butler, D.L. and Awad, H.A. (1999) Perspectives on cell and collagen composites for tendon repair. Clin. Orthop. 367 Suppl: S324–332.
Shapiro, L. and Cohen, S. (1997) Novel alginate sponges for cell culture and transplantation. Biomaterials 18 (8): 583–590.
Matsumoto, T.; Kawai, M. and Masuda, T. (1992) influence of concentration and mannuronate/guluronate [correction of gluronate] ratio on steady flow properties of alginate aqueous systems. Biorheology 29(4): 411–417.
Eiselt, P.; Lee, K.Y. and Mooney, D.J. (1999) Rigidity of two-component hydrogels prepared from alginate andpoly(ethylene glycol)-diamines. Macromolecules 32 (17): 5561–5566.
Lee, K.Y.; Rowley, J.A; Eiselt, P.; Moy, E.M.; Bouhadir, K.H. and Mooney, D.J. (2000) Controlling mechanical and swelling properites of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules 33 (11): 4291–4294.
Lee, K.Y. and Mooney, D.J. (2001) Hydrogels for tissue engineering. Chem. Rev. 101 (7): 1869–1879.
Smetana, K., Jr. (1993) Cell biology of hydrogels. Biomaterials 14 (14): 1046–1050.
Rowley, J.A. and Mooney, D.J. (2002) Alginate type and RGD density control myoblast phenotype. J. Biomed. Mater. Res. 60 (2): 217–223.
Paige, K.T.; Cima, L.G.; Yaremchuk, M.J.; Vacanti, J.P. and Vacanti, C.A. (1995) Injectable cartilage. Plast. Reconstr. Surg. 96 (6): 1390–1400.
Gutowska, A.; Jeong, B. and Jasionowski, M. (2001) Injectable gels for tissue engineering. Anat. Rec. 263 (4): 342–349.
Pouyani, T. and Prestwich, G.D. (1994) Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. Bioconjug. Chem. 5 (4): 339–347.
Afify, A.M.; Stern, M.; Guntenhoner, M. and Stern, R. (1993) Purification and characterization of human serum hyaluronidase. Arch. Biochem. Biophys. 305 (2): 434–441.
Radice, M.; Brun, P.; Cortivo, R.; Scapinelli, R.; Battaliard, C. and Abatangelo, G. (2000) Hyaluronanbased biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J. Biomed. Mater. Res. 50 (2): 101–109.
Liu, L.S.; Thompson, A.Y.; Heidaran, M.A.; Poser, J.W. and Spiro, R.C. (1999) An osteoconductive collagen/hyaluronate matrix for bone regeneration. Biomaterials 20 (12) 1097–1108.
Chenite, A.; Chaput, C.; Wang, D.; Combes, C.; Buschmann, M.D.; Hoemann, C.D.; Leroux, J.C.; Atkinson, B.L.; Binette, F. and Selmani, A. (2000) Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21 (21): 2155–2161.
Monteiro, O.A., Jr. and Airoldi, C. (1999) Some studies of crosslinking chitosan-glutaraldehyde interaction in a homogeneous system. Int. J. Biol. Macromol. 26 (2–3): 119–128.
Varum, K.M.; Myhr, M.M.; Hjerde, R.J. and Smidsrod, O. (1997) In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr. Res. 299(1–2): 99–101.
Aiedeh, K.; Gianasi, E.; Orienti, 1. and Zecchi, V. (1997) Chitosan microcapsules as controlled release systems for insulin. J. Microencapsul. 14 (5): 567–576.
Muzzarelli, R.; Baldassarre, V.; Conti, F.; Ferrara, P.; Biagini, G.; Gazzanelli, G. and Vasi, V. (1988) Biological activity of chitosan: ultrastructural study. Biomaterials 9 (3): 247–252.
Tan, W.; Krishnaraj, R. and Desai, T.A. (2001) Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering. Tissue Eng. 7 (2): 203–210.
Iwata, H.; Amemiya, H.; Matsuda, T.; Takano, H.; Hayashi, R. and Akutsu, T. (1989) Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes. 38 (Suppl. 1): 224–225.
Rahfoth, B.; Weisser, J.; Stemkopf, F.; Aigner, T.; von der Mark, K. and Brauer, R. (1998) Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthritis Cartilage 6 (1): 50–65.
Seppala, J.V.; Korhonen, H.; Kylma, J. and Tuominen, J. (2002) General Methodology for Chemical Synthesis of Polyesters. In: Yoshiharu, D. and Steinbüchel, A. (Eds.) Biopolymers, Vol. 3b: Polyesters II - Properties and Chemical Synthesis. Wiley-VCH, Weinheim; pp. 327–370.
Hollinger, J.O. and Schmitz, J.P. (1987) Restoration of bone discontinuities in dogs using a biodegradable implant. J. Oral Maxillofac. Surg. 45 (7): 594–600.
Mayer, J.; Karamuk, E.; Akaike, T. and Wintermantel, E. (2000) Matrices for tissue engineering-scaffold structure for a bioartificial liver support system. J. Control. Release 64 (1–3): 81–90.
Widmer, M.S.; Gupta, P.K.; Lu, L.; Meszlenyi, R.K.; Evans, G.R.; Brandt, K.; Savel, T.; Gurlek, A.; Patrick, C.W., Jr. and Mikos, A.G. (1998) Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials 19 (21): 1945–1955.
Domb, A.J.; Amselem, S.; Langer, R. and Maniar, M. (1994) Polyanhydrides as carriers of drugs. In: Shalaby, W.S. (Ed.) Biomedical Polymers. Hanser Publishers, Munich (Germany); pp. 69–96.
Ibim, S.E.; Uhrich, K.E.; Attawia, M.; Shastri, V.R.; El-Amin, S.F.; Bronson, R.; Langer, R. and Laurencin, C.T. (1998) Preliminary in vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial model. J. Biomed. Mater. Res. 43 (4): 374–379.
Ibim, S.M.; Uhrich, K.E.; Bronson, R.; El-Amin, S.F.; Langer, R.S. and Laurencin, C.T. (1998) Poly(anhydride-co-imides): in vivo biocompatibility in a rat model. Biomaterials 19 (10): 941–951.
Anseth, K.S.; Svaldi, D.C.; Laurencin, C.T. and Langer, R. (1997) Potopolymerization of novel degradable networks for orthopaedic applications. In: Scranton, A.B.; Christopher, N.B. and Peiffer, R.W. (Eds.) Photopolymerizaion: fundamentals and applications. American Chemical Society, Washington D.C.; pp. 189–202.
Burkoth, A.K. and Anseth, K.S. (2000) A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials 21 (23): 2395–2404.
Fu, K.; Pack, D.W.; Klibanov, A.M. and Langer, R. (2000) Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 17 (1): 100–106.
Sawhney, A.S. (1999) Poly(ethylene glycol). In: Kuhtreiber, W.M.; Lanza, R.P. and Chick, W.L. (Eds.) Cell encapsulation technology and therapeutics. Birkhauser, Boston; pp. 108–116.
Sawhney, A.S. and Hubbell, J.A. (1992) Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes. Biomaterials 13(12) 863870.
Metters, A.T.; Bowman, C.N. and Anseth, K.S. (2000) A statistical kinetic model for the bulk degradation of PLA-b-PEG-b-PLA hydrogel networks. Journal of Physical Chemistry 104: 7043–7049.
Bryant, S.J. and Anseth, K.S. (2002) Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J. Biomed. Mater. Res. 59 (1) 63–72.
Dupuy, B.; Gin, H.; Baquey, C. and Ducassou, D. (1988) In situ polymerization of a microencapsulating medium round living cells. J. Biomed. Mater. Res. 22(11) 1061–1070.
Zuk, P.A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J.W.; Katz, A.J.; Benhaim, P.; Lorenz, H.P. and Hedrick, M.H. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7 (2): 211–228.
Heath, C.A. (2000) Cells for tissue engineering. Trends Biotechnol. 18 (1): 17–19.
Oreffo, R.O. and Triffitt, J.T. (1999) Future potentials for using osteogenic stem cells and biomaterials in orthopedics. Bone 25 (2 Suppl): 5S - 9S.
Fontaine, M.; Hansen, L.K.; Thompson, S.; Uyama, S.; Ingber, D.E.; Langer, R. and Vacanti, J.P. (1993) Transplantation of genetically altered hepatocytes using cell-polymer constructs. Transplant. Proc. 25 (1 Pt 2): 1002–1004.
Giordano, R.A.; Wu, B.M.; Borland, S.W.; Cima, L.G.; Sachs, E.M. and Cima, M.J. (1996) Mechanical properties of dense polylactic acid structures fabridated by three dimensional printing. J. Biomater. Sci. Polym. Ed. 8(1): 63–75.
Griffith, L.G.; Wu, B.; Cima, M.J.; Powers, M.J.; Chaignaud, B. and Vacanti, J.P. (1997) In vitro organogenesis of liver tissue. Ann. N.Y. Acad. Sci. 831: 382–397.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Riddle, K.W., Mooney, D.J. (2004). Biomaterials for Cell Immobilization. In: Nedović, V., Willaert, R. (eds) Fundamentals of Cell Immobilisation Biotechnology. Focus on Biotechnology, vol 8A. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1638-3_1
Download citation
DOI: https://doi.org/10.1007/978-94-017-1638-3_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6534-6
Online ISBN: 978-94-017-1638-3
eBook Packages: Springer Book Archive